cis-Mulberroside A exhibits anti-inflammatory and anti-apoptotic activities; it inhibits the expression of TNF-α, IL-1β, and IL-6, suppresses the activation of NALP3, caspase-1, and NF-κB, and inhibits the phosphorylation of ERK, JNK, and p38; it shows tyrosinase inhibitory activity with an IC50 of 53.6 μM; it reduces serum uric acid levels and increases urinary urate excretion and fractional excretion of uric acid in hyperuricemic mice.